Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter?

Vaccine

Volumn 27, Issue 42, 2009, Pages 5865-5869

  Afsar, Baris ^a   Elsurer, Rengin ^b   Eyileten, Tayfun ^a   Yilmaz, M Ilker ^a   Caglar, Kayser ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Zonguldak Ataturk State Hospital   (Turkey)

Author keywords

Antibody; Depression; Hemodialysis; Hepatitis B virus; Quality of life; Vaccine

Indexed keywords

ALBUMIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SEROCONVERSION; SHORT FORM 36;

ADULT; ANTIBODY FORMATION; DEPRESSION; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RENAL DIALYSIS; VACCINATION;

EID: 69749114961     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.055     Document Type: Article

References (39)

1. Cheng C.H., Huang C.C., Leu M.L., Chiang C.Y., Wu M.S., Lai P.C., et al. B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 15 12-13 (1997) 1353-1357
2. Kara I.H., Yilmaz M.E., Suner A., Kadiroglu A.K., and Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 28 22 (2004) 3963-3967
3. Chow K.M., Law M.C., Leung C.B., Szeto C.C., and Li P.K. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 103 3 (2006) c89-c93 [Epub 2006 March 13]
4. Buti M., Viladomiu L., Jardi R., Olmos A., Rodriguez J.A., Bartolome J., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 12 3 (1992) 144-147
5. DaRoza G., Loewen A., Djurdjev O., Love J., Kempston C., Burnett S., et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 42 6 (2003) 1184-1192
6. Sjogren M.H. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med 118 Suppl. 10A (2005) 34S-39S
7. Lin H.H., Liao H.W., Lin S.K., and Wang L.Y. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 26 June (27-28) (2008) 3414-3420
8. Wang L.Y., and Lin H.H. Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. J Hepatol 46 6 (2007) 1018-1025
9. Chan R., Brooks R., Erlich J., Chow J., and Suranyi M. The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator. Clin J Am Soc Nephrol 4 1 (2009) 160-167
10. Kimmel P.L., and Peterson R.A. Depression in end-stage renal disease patients treated with hemodialysis: tools, correlates, outcomes, and needs. Semin Dial 18 2 (2005) 91-97
11. Whalley B., Jacobs P.A., and Hyland M.E. Correlation of psychological and physical symptoms with chronically elevated cytokine levels associated with a common immune dysregulation. Ann Allergy Asthma Immunol 99 4 (2007) 348-351
12. Zhou F.L., Zhang W.G., Wei Y.C., Xu K.L., Hui L.Y., Wang X.S., et al. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J Gastroenterol 11 15 (2005) 2313-2318
13. Mozaffari H., Pourpak Z., Pourseyed S., Moin M., Farhoodi A., Aghamohammadi A., et al. Health-related quality of life in primary immune deficient patients. Iran J Allergy Asthma Immunol 5 1 (2006) 23-27
14. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 June (1961) 561-571
15. Koo J.R., Yoon J.W., Kim S.G., Lee Y.K., Oh K.H., Kim G.H., et al. Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 41 5 (2003) 1037-1042
16. Ware Jr. J.E., and Sherbourne C.D. The MOS 36 item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 6 (1992) 473-483
17. Koçyigit H., Aydemir O., and Fişek G. Ki{dotless}sa form 36 (KF-36)'ni{dotless}n Türkçe versiyonunun güvenilirliǧi ve geçerliligi. İlaç ve Tedavi Dergisi 12 (1999) 102-106
18. Johansen K.L., Painter P., Kent-Braun J.A., Ng A.V., Carey S., Da Silva M., et al. Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. Kidney Int 59 3 (2001) 1121-1127
19. Liu Y.L., Kao M.T., and Huang C.C. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 23 30 (2005) 3957-3960 [Epub 2005 March 27]
20. Mauri J.M., and Vallès M. Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients. Collaborative Group of Girona. Nephrol Dial Transplant 12 4 (1997) 729-732
21. el-Reshaid K., al-Mufti S., Johny K.V., and Sugathan T.N. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 12 3 (1994) 223-234
22. Kronfol Z. Immune dysregulation in major depression: a critical review of existing evidence. Int J Neuropsychopharmacol 5 4 (2002) 333-343
23. Leonard B.E. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 25 4 (2001) 767-780
24. Ouzouni S., Kouidi E., Sioulis A., Grekas D., and Deligiannis A. Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil 23 1 (2009) 53-63
25. Brenner I., and Brohart K. Weekly energy expenditure and quality of life in hemodialysis patients. CANNT J 18 4 (2008) 36-40
26. Capitanini A., Cupisti A., Mochi N., Rossini D., Lupi A., Michelotti G., et al. Effects of exercise training on exercise aerobic capacity and quality of life in hemodialysis patients. J Nephrol 21 5 (2008) 738-743
27. Drela N., Kozdron E., and Szczypiorski P. Moderate exercise may attenuate some aspects of immunosenescence. BMC Geriatr 29 September (4) (2004) 8
28. Shimizu K., Kimura F., Akimoto T., Akama T., Tanabe K., Nishijima T., et al. Effect of moderate exercise training on T-helper cell subpopulations in elderly people. Exerc Immunol Rev 14 (2008) 24-37
29. Suzuki K., and Tagami K. Voluntary wheel-running exercise enhances antigen-specific antibody-producing splenic B cell response and prolongs IgG half-life in the blood. Eur J Appl Physiol 94 5-6 (2005) 514-519
30. Kalantar-Zadeh K., Kopple J.D., Block G., and Humphreys M.H. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12 12 (2001) 2797-2806
31. Kalantar-Zadeh K., Block G., McAllister C.J., Humphreys M.H., and Kopple J.D. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80 2 (2004) 299-307
32. Fernandez E., Betriu M.A., Gomez R., and Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 11 8 (1996) 1559-1563
33. Dacko C., and Holley J.L. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients. Adv Perit Dial 12 (1996) 315-317
34. Niiya T., Akbar S.M., Yoshida O., Miyake T., Matsuura B., Murakami H., et al. Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice. J Nutr 137 3 (2007) 671-675
35. Steketee R.W., Ziarnik M.E., and Davis J.P. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin. Am J Epidemiol 127 4 (1988) 772-782
36. Wood R.C., MacDonald K.L., White K.E., Hedberg C.W., Hanson M., and Osterholm M.T. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 270 24 (1993) 2935-2939
37. Ibrahim S., el-Din S., and Bazzal I. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status. J Natl Med Assoc 98 12 (2006) 1953-1957
38. Tele S.A., Martins R.M., Lopes C.L., dos Santos Carneiro M.A., Souza K.P., and Yoshida C.F. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol 17 2 (2001) 145-149
39. Roozbeh J., Moini M., Lankarani K.B., Sagheb M.M., Shahpoori S., and Bastani B. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. ASAIO J 51 3 (2005) 242-245